Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -- produced from healthy and tumour cells from the patient him or herself -- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

Read the whole article on Science Blog

More from Science Blog